RegentAtlantic Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$2.62M Buy
3,798
+93
+3% +$64.1K 0.08% 173
2022
Q2
$2.19M Sell
3,705
-166
-4% -$98.1K 0.07% 198
2022
Q1
$2.7M Buy
3,871
+89
+2% +$62.2K 0.08% 186
2021
Q4
$2.39M Buy
3,782
+13
+0.3% +$8.21K 0.07% 199
2021
Q3
$2.28M Sell
3,769
-591
-14% -$358K 0.07% 193
2021
Q2
$2.44M Sell
4,360
-960
-18% -$536K 0.07% 182
2021
Q1
$2.52M Sell
5,320
-1,189
-18% -$563K 0.09% 169
2020
Q4
$3.15M Sell
6,509
-6,170
-49% -$2.98M 0.12% 128
2020
Q3
$7.1M Buy
12,679
+6,121
+93% +$3.43M 0.32% 66
2020
Q2
$4.09M Buy
6,558
+5,590
+577% +$3.49M 0.23% 92
2020
Q1
$473K Buy
968
+193
+25% +$94.3K 0.04% 276
2019
Q4
$291K Buy
+775
New +$291K 0.02% 386
2019
Q2
Sell
-532
Closed -$218K 444
2019
Q1
$218K Sell
532
-12
-2% -$4.92K 0.02% 410
2018
Q4
$203K Buy
544
+12
+2% +$4.48K 0.02% 391
2018
Q3
$215K Sell
532
-100
-16% -$40.4K 0.02% 414
2018
Q2
$218K Hold
632
0.02% 383
2018
Q1
$218K Buy
632
+60
+10% +$20.7K 0.02% 391
2017
Q4
$215K Buy
572
+35
+7% +$13.2K 0.02% 404
2017
Q3
$240K Hold
537
0.02% 377
2017
Q2
$264K Buy
537
+5
+0.9% +$2.46K 0.02% 351
2017
Q1
$206K Sell
532
-30
-5% -$11.6K 0.02% 382
2016
Q4
$206K Buy
562
+10
+2% +$3.67K 0.02% 375
2016
Q3
$222K Buy
+552
New +$222K 0.02% 359
2016
Q1
Sell
-532
Closed -$289K 390
2015
Q4
$289K Sell
532
-1
-0.2% -$543 0.03% 316
2015
Q3
$248K Hold
533
0.02% 332
2015
Q2
$272K Hold
533
0.02% 324
2015
Q1
$241K Sell
533
-56
-10% -$25.3K 0.02% 323
2014
Q4
$242K Hold
589
0.02% 329
2014
Q3
$212K Buy
+589
New +$212K 0.02% 343
2014
Q2
Sell
-851
Closed -$256K 364
2014
Q1
$256K Buy
+851
New +$256K 0.03% 311
2013
Q4
Sell
-1,560
Closed -$488K 359
2013
Q3
$488K Buy
+1,560
New +$488K 0.05% 234